Omesti Bhd (XKLS:9008) Marketable Securities: RM26.95 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Omesti Bhd Marketable Securities?

Omesti Bhd XKLS:9008 Marketable Securities is RM26.95 Mil as of Apr. 2026. The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Omesti Bhd's Marketable Securities for the quarter that ended in Apr. 2026 was RM26.95 Mil.

Omesti Bhd's annual Marketable Securities declined from Mar. 2022 (RM4.48 Mil) to Mar. 2023 (RM0.00 Mil) but then stayed the same from Mar. 2023 (RM0.00 Mil) to Mar. 2024 (RM0.00 Mil).

Omesti Bhd  (XKLS:9008) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Omesti Bhd Marketable Securities Related Terms

Omesti Bhd Marketable Securities Historical Data

* Premium members only.

The historical data trend for Omesti Bhd's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omesti Bhd Marketable Securities Chart

Omesti Bhd Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.10 4.48 0.00 0.00

Omesti Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Jan26 Apr26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 27.07 26.95

Omesti Bhd Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of RM26.95 Mil mean?
Omesti Bhd (XKLS:9008) has a Marketable Securities of RM26.95 Mil as of Apr. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Omesti Bhd and its competitors.
Is Omesti Bhd's Marketable Securities too high?
Omesti Bhd's current Marketable Securities is RM26.95 Mil.
How does Omesti Bhd's Marketable Securities compare to CTAS and CPRT?
Omesti Bhd's Marketable Securities of RM26.95 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Business Services company?
A good Marketable Securities depends on the Business Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Omesti Bhd and its competitors. Omesti Bhd's current Marketable Securities is RM26.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omesti Bhd stock overvalued right now?
Based on GuruFocus' analysis, Omesti Bhd (XKLS:9008) is currently considered Fairly Valued. The stock's GF Value™ is RM0.06, compared to a current price of RM0.07 — trading 8.3% above its estimated fair value. The current Marketable Securities is RM26.95 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Omesti Bhd (XKLS:9008), the current Marketable Securities is RM26.95 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omesti Bhd Business Description

Address No. 1 Persiaran Jalil 1, Bandar Bukit Jalil, 2-07-01 - Level 7, Plaza Bukit Jalil, Ho Hup Tower - Aurora Place, Kuala Lumpur, SGR, MYS, 57000
Omesti Bhd is focused on the delivery of technology solutions, systems integration services and the provision of recurring maintenance and managed services, predominantly for government and public sector customers. Its segments include Business Performance Services engages in provision of business performance improvement related services; Digital and Infrastructure Services engaged in the provision of a comprehensive range of tele/data communication, networking solutions and related services; and Healthcare Services engaged in the distribution of pharmaceutical products, vaccines and medical devices and provision of various medical services. The majority of the revenue is derived from Business Performance Services segment.